Wetherby Asset Management Inc Edwards Lifesciences Corp Transaction History

Wetherby Asset Management Inc

  • $2.19 Billion
  • Q2 2025

A detailed history of Wetherby Asset Management Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wetherby Asset Management Inc holds 7,724 shares of EW stock, worth $585,015. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,724
Previous 8,336 7.34%
Holding current value
$585,015
Previous $617,000 2.11%
% of portfolio
0.03%
Previous 0.03%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$67.07 - $78.22 $41,046 - $47,870
-612 Reduced 7.34%
7,724 $604,000
Q4 2024

Feb 14, 2025
SELL
$64.54 - $75.92 $34,206 - $40,237
-530 Reduced 5.98%
8,336 $617,000
Q3 2024

Nov 14, 2024
SELL
$59.7 - $93.78 $146,862 - $230,698
-2,460 Reduced 21.72%
8,866 $585,000
Q2 2024

Aug 14, 2024
SELL
$84.3 - $94.31 $21,159 - $23,671
-251 Reduced 2.17%
11,326 $1.05 Million
Q1 2024

May 15, 2024
BUY
$72.54 - $95.56 $16,394 - $21,596
226 Added 1.99%
11,577 $1.11 Million
Q4 2023

Feb 14, 2024
SELL
$61.71 - $77.76 $5,862 - $7,387
-95 Reduced 0.83%
11,351 $865,000
Q3 2023

Nov 14, 2023
SELL
$69.28 - $93.38 $222,804 - $300,310
-3,216 Reduced 21.93%
11,446 $792,000
Q2 2023

Aug 14, 2023
SELL
$81.41 - $94.33 $54,951 - $63,672
-675 Reduced 4.4%
14,662 $1.38 Million
Q1 2023

May 12, 2023
BUY
$74.26 - $84.51 $189,140 - $215,246
2,547 Added 19.91%
15,337 $1.27 Million
Q4 2022

Feb 14, 2023
SELL
$68.3 - $87.44 $58,601 - $75,023
-858 Reduced 6.29%
12,790 $954,000
Q3 2022

Nov 14, 2022
BUY
$82.37 - $107.29 $135,992 - $177,135
1,651 Added 13.76%
13,648 $1.13 Million
Q2 2022

Aug 15, 2022
SELL
$86.5 - $128.27 $79,666 - $118,136
-921 Reduced 7.13%
11,997 $1.14 Million
Q1 2022

May 16, 2022
SELL
$101.96 - $128.34 $33,952 - $42,737
-333 Reduced 2.51%
12,918 $1.52 Million
Q4 2021

Feb 14, 2022
BUY
$106.37 - $130.68 $76,692 - $94,220
721 Added 5.75%
13,251 $1.72 Million
Q3 2021

Nov 15, 2021
BUY
$102.91 - $122.75 $27,271 - $32,528
265 Added 2.16%
12,530 $1.42 Million
Q2 2021

Aug 16, 2021
BUY
$83.84 - $104.76 $52,064 - $65,055
621 Added 5.33%
12,265 $1.27 Million
Q1 2021

May 14, 2021
SELL
$78.68 - $90.67 $40,441 - $46,604
-514 Reduced 4.23%
11,644 $973,000
Q4 2020

Feb 11, 2021
BUY
$71.69 - $91.23 $814,613 - $1.04 Million
11,363 Added 1429.31%
12,158 $1.11 Million
Q3 2020

Dec 16, 2020
SELL
$67.19 - $87.44 $680,701 - $885,854
-10,131 Reduced 92.72%
795 $63,000
Q3 2020

Dec 16, 2020
SELL
$67.19 - $87.44 $81,434 - $105,977
-1,212 Reduced 9.99%
10,926 $872,000
Q3 2020

Nov 13, 2020
BUY
$67.19 - $87.44 $4,165 - $5,421
62 Added 0.51%
12,138 $969,000
Q2 2020

Aug 14, 2020
BUY
$57.54 - $76.95 $492,945 - $659,230
8,567 Added 244.14%
12,076 $834,000
Q1 2020

May 06, 2020
SELL
$52.41 - $81.0 $7,442 - $11,502
-142 Reduced 3.89%
3,509 $662,000
Q4 2019

Jan 28, 2020
BUY
$71.7 - $82.09 $7,958 - $9,111
111 Added 3.14%
3,651 $852,000
Q3 2019

Oct 31, 2019
BUY
$61.55 - $75.43 $14,772 - $18,103
240 Added 7.27%
3,540 $779,000
Q2 2019

Jul 25, 2019
BUY
$55.74 - $64.41 $1,504 - $1,739
27 Added 0.82%
3,300 $610,000
Q1 2019

May 09, 2019
BUY
$47.89 - $64.05 $16,138 - $21,584
337 Added 11.48%
3,273 $626,000
Q4 2018

Jan 30, 2019
BUY
$46.41 - $56.94 $35,085 - $43,046
756 Added 34.68%
2,936 $450,000
Q3 2018

Nov 07, 2018
SELL
$45.7 - $58.03 $2,056 - $2,611
-45 Reduced 2.02%
2,180 $379,000
Q2 2018

Jul 24, 2018
BUY
$42.45 - $51.3 $2,122 - $2,565
50 Added 2.3%
2,225 $323,000
Q1 2018

May 04, 2018
BUY
$37.19 - $47.45 $9,818 - $12,526
264 Added 13.81%
2,175 $303,000
Q4 2017

Feb 09, 2018
BUY
$33.79 - $39.39 $777 - $905
23 Added 1.22%
1,911 $215,000
Q3 2017

Nov 13, 2017
BUY
$36.29 - $38.83 $68,515 - $73,311
1,888
1,888 $206,000

Others Institutions Holding EW

# of Institutions
1,445
Shares Held
483M
Call Options Held
2.76M
Put Options Held
1.54M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email